BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29934472)

  • 21. HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cells.
    Goeser F; Glässner A; Kokordelis P; Wolter F; Lutz P; Kaczmarek DJ; Schwarze-Zander C; Boesecke C; Strassburg CP; Rockstroh JK; Spengler U; Krämer B; Nattermann J
    AIDS; 2016 Jan; 30(3):355-63. PubMed ID: 26558728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects.
    Boaz MJ; Waters A; Murad S; Easterbrook PJ; D'Sousa E; van Wheeley C; Vyakarnam A
    Clin Exp Immunol; 2003 Dec; 134(3):454-63. PubMed ID: 14632751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged Antiretroviral Therapy in Adolescents With Vertical HIV Infection Leads to Different Cytokine Profiles Depending on Viremia Persistence.
    Munhoz LGC; Garcia Spina F; Machado DM; Gouvea A; Succi RCM; Diaz RS; De Moraes-Pinto MI
    Pediatr Infect Dis J; 2019 Nov; 38(11):1115-1120. PubMed ID: 31626046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.
    Papasavvas E; Foulkes A; Yin X; Joseph J; Ross B; Azzoni L; Kostman JR; Mounzer K; Shull J; Montaner LJ
    Immunology; 2015 Jul; 145(3):380-90. PubMed ID: 25684333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
    Tan DB; Fernandez S; French M; Price P
    Clin Immunol; 2009 Jul; 132(1):63-70. PubMed ID: 19403337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of the CD8
    Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
    Front Immunol; 2021; 12():687296. PubMed ID: 34177939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.
    Chehimi J; Azzoni L; Farabaugh M; Creer SA; Tomescu C; Hancock A; Mackiewicz A; D'Alessandro L; Ghanekar S; Foulkes AS; Mounzer K; Kostman J; Montaner LJ
    J Immunol; 2007 Aug; 179(4):2642-50. PubMed ID: 17675528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.
    Michaëlsson J; Long BR; Loo CP; Lanier LL; Spotts G; Hecht FM; Nixon DF
    J Infect Dis; 2008 Jan; 197(1):117-25. PubMed ID: 18171294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK cells are primed by ANRS MVA(HIV)-infected DCs, via a mechanism involving NKG2D and membrane-bound IL-15, to control HIV-1 infection in CD4+ T cells.
    Moreno-Nieves UY; Didier C; Lévy Y; Barré-Sinoussi F; Scott-Algara D;
    Eur J Immunol; 2014 Aug; 44(8):2370-9. PubMed ID: 24777763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
    Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
    J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells.
    Zhao NQ; Ferreira AM; Grant PM; Holmes S; Blish CA
    Front Immunol; 2020; 11():829. PubMed ID: 32477342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
    Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
    J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.
    Dybul M; Mercier G; Belson M; Hallahan CW; Liu S; Perry C; Herpin B; Ehler L; Davey RT; Metcalf JA; Mican JM; Seder RA; Fauci AS
    J Immunol; 2000 Aug; 165(3):1685-91. PubMed ID: 10903780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.
    de Armas LR; Pallikkuth S; Rinaldi S; Pahwa R; Pahwa S
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1112-1122. PubMed ID: 31578868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype.
    Riou C; Tanko RF; Soares AP; Masson L; Werner L; Garrett NJ; Samsunder N; Karim QA; Karim SSA; Burgers WA
    J Immunol; 2015 Sep; 195(5):2273-2281. PubMed ID: 26195814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.